Corepath Wealth Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.15M |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$1.54M |
| 3 |
iShares Core S&P US Value ETF
IUSV
|
+$1.12M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$893K |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$726K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
|
+$668K |
| 2 |
Intel
INTC
|
+$19.8K |
| 3 |
Apple
AAPL
|
+$13.6K |
| 4 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$1.64K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 0.96% |
| 2 | Healthcare | 0.41% |
| 3 | Consumer Staples | 0.36% |
| 4 | Industrials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
3M
MMM
$87.7B
| $463K | 0.36% |
2,794
| – | – |
|
27
Target
TGT
$61.1B
| $463K | 0.36% |
1,781
| – | – |
|
|
NVTA
28
DELISTED
Invitae Corporation
NVTA
| $460K | 0.36% |
15,500
+6,000
| +63% | +$195K |
|
29
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.15B
| $399K | 0.31% |
5,595
+866
| +18% | +$60.2K |
|
30
Fidelity MSCI Health Care Index ETF
FHLC
$3.25B
| $345K | 0.27% |
5,189
| – | – |
|
31
Vanguard Total International Stock ETF
VXUS
$153B
| $317K | 0.25% |
4,845
| – | – |
|
32
Johnson & Johnson
JNJ
$624B
| $316K | 0.24% |
1,827
| – | – |
|
33
iShares Russell 2000 Growth ETF
IWO
$14.5B
| $273K | 0.21% |
902
| – | – |
|
34
Vanguard Small-Cap Value ETF
VBR
$36.7B
| $263K | 0.2% |
1,524
| – | – |
|
35
iShares Core S&P Small-Cap ETF
IJR
$109B
| $250K | 0.19% |
2,246
+200
| +10% | +$22.3K |
|
36
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.62B
| $242K | 0.19% |
+4,286
| New | +$237K |
|
|
37
Apple
AAPL
$4.71T
| $222K | 0.17% |
1,517
-105
| -6% | -$13.6K |
|
38
Fate Therapeutics
FATE
$296M
| $215K | 0.17% |
+2,250
| New | +$181K |
|
Similar funds
Corepath Wealth Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Corepath Wealth Partners held 38 positions worth $129M, up 14% from $114M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Corepath Wealth Partners deployed $12M of net new capital in Q2 2021, opening 2 new positions and adding to 17 existing holdings. Its largest new stake was iShares Core 60/40 Balanced Allocation ETF: 4,286 shares worth $242K.
By sector, the portfolio is most concentrated in Technology at 0.96% of assets, down from 1.3% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was VictoryShares US EQ Income Enhanced Volatility Wtd ETF, an estimated $668K trimmed.
- Corepath Wealth Partners's largest Q2 2021 buy was iShares Core 60/40 Balanced Allocation ETF: 4,286 shares worth $242K.
- Corepath Wealth Partners added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $4.15M increase.
- Corepath Wealth Partners's biggest Q2 2021 reduction was VictoryShares US EQ Income Enhanced Volatility Wtd ETF, cutting an estimated $668K.
- Corepath Wealth Partners's ten largest holdings make up 81% of its $129M portfolio in Q2 2021.
- Corepath Wealth Partners opened 2 new positions and closed 0 in Q2 2021.
- Corepath Wealth Partners's portfolio value rose 14% quarter-over-quarter to $129M.
Based on Corepath Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.